title: Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases.
authors.affiliation: Dept. of Surgery, University of Pittsburgh Medical Center, PA 15213.
authors.forename: N L
authors.initials: NL
authors.lastname: Nikolaidis
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: A W
authors.initials: AW
authors.lastname: Thomson
authors.forename: H R
authors.initials: HR
authors.lastname: Rilo
authors.forename: W D
authors.initials: WD
authors.lastname: Irish
authors.forename: D H
authors.initials: DH
authors.lastname: Van Thiel
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D011565:Psoriasis / Q000188:drug therapy* / Q000503:physiopathology; D016559:Tacrolimus / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood
chemical_list: D001786:Blood Glucose; D014527:Uric Acid; D002784:Cholesterol; D003404:Creatinine; D016559:Tacrolimus